According to the SEC Form 4 filings, WAGNER CHARLES F JR, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $10,778,252 | 2 | 100 |
| 2026-01-06 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, CO & FO | 9,532 0.0038% | $461.00 | $4.39M | +1.81% | |
| 2025-12-03 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, CO & FO | 14,000 0.0054% | $456.00 | $6.38M | +1.62% | |
| 2025-03-10 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 3,298 0.0013% | $500.00 | $1.65M | -10% | |
| 2024-11-11 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 3,000 0.0012% | $518.27 | $1.55M | -10.88% | |
| 2024-06-03 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 3,250 0.0012% | $460.00 | $1.5M | +0.93% | |
| 2024-05-28 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 3,250 0.0013% | $454.79 | $1.48M | +6.19% | |
| 2024-01-02 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 3,000 0.0011% | $405.00 | $1.22M | +12.37% | |
| 2023-11-20 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 3,000 0.0011% | $349.88 | $1.05M | +24.98% | |
| 2023-03-24 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 1,768 0.0007% | $305.38 | $539,912 | +11.95% | |
| 2023-03-17 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 2,000 0.0008% | $296.39 | $592,786 | +18.74% | |
| 2023-03-13 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 2,666 0.001% | $293.83 | $783,346 | +19.57% | |
| 2023-03-10 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 2,088 0.0008% | $289.61 | $604,709 | +22.11% | |
| 2022-05-02 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 80 <0.0001% | $259.45 | $20,756 | +11.94% | |
| 2022-04-01 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 536 0.0002% | $265.95 | $142,549 | +9.28% | |
| 2022-03-17 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 3,110 0.0012% | $250.13 | $777,904 | +15.88% | |
| 2022-02-02 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 2,944 0.0011% | $250.07 | $736,206 | +12.81% | |
| 2020-07-10 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP & Chief Financial Officer | 700 0.0003% | $293.15 | $205,206 | -25.69% | |
| 2015-03-17 | Sale | Bruker Corporation BRKR | EVP & Chief Financial Officer | 19,000 0.0113% | $18.97 | $360,493 | +8.28% |